UNSPSC 51314341: Chlorpheniramine/guaifenesin/phenylephrine/phenylpropanolamine/p

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE503. This VA Drug Class (RE503) classifies this compound as belonging to the group ANTIHISTAMINE/DECONGESTANT/EXPECTORANT.

UNSPSC 51314341 Chlorpheniramine/guaifenesin/phenylephrine/phenylpropanolamine is a Commodity code that does not align with the state and local procurement activity currently tagged under it. The recent opportunities reflect procurement of naloxone and drug deactivation systems, direct-to-manufacturer prescription programs, and generic multi-source pharmaceuticals through cooperative purchasing vehicles — none of which involve the specific combination cold/allergy remedy identified by the code's name.

The mismatch between the code's nominal scope and actual usage suggests this Commodity code sees little relevant recent activity in state and local procurement. Buyers pursuing opportunities under this code should verify that tagging accuracy with issuing bodies before pursuing bids, as the code as currently applied does not signal a coherent product line or service category.